US Stock MarketDetailed Quotes

BRNS Barinthus Biotherapeutics

Watchlist

0.975
-0.011-1.09%

Trading Dec 2 12:01 ET

39.23MMarket Cap-654P/E (TTM)

Barinthus Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-62.61%-18.2M

29.20%-12.01M

-272.46%-11.82M

-252.89%-50.93M

-72.82%-19.6M

-194.17%-11.19M

-102.04%-16.96M

51.76%-3.17M

55.71%-14.43M

-42.29%-11.34M

Net income from continuing operations

42.39%-8.13M

28.88%-16.94M

14.83%-15.52M

-1,480.32%-73.45M

18.30%-17.29M

-271.63%-14.11M

-251.85%-23.82M

-807.96%-18.22M

110.41%5.32M

-39.50%-21.16M

Operating gains losses

141.73%2.61M

-87.76%443K

-129.28%-1.03M

129.82%7.53M

-43.01%6.65M

65.69%-6.24M

--3.62M

--3.5M

-432.89%-25.25M

--11.67M

Depreciation and amortization

0.07%1.48M

12.93%1.47M

17.12%1.43M

25.58%5.43M

21.92%1.44M

24.07%1.47M

30.95%1.3M

26.40%1.22M

618.11%4.32M

266.67%1.18M

Deferred tax

99.50%-3K

99.38%-7K

92.83%-37K

29.10%-3.08M

57.55%-821K

3.68%-602K

-24.15%-1.14M

40.21%-516K

-3,544.54%-4.34M

-3,292.98%-1.93M

Other non cash items

108.33%2K

-30.87%383K

18.41%431K

21.43%1.41M

191.18%517K

-104.17%-24K

-28.15%554K

-4.96%364K

0.96%1.16M

-262.93%-567K

Change In working capital

-285.20%-15.29M

168.63%1.46M

-84.43%1.29M

211.71%6.17M

-323.42%-10.88M

-57.91%8.26M

106.06%542K

160.59%8.25M

23.04%-5.52M

-185.47%-2.57M

-Change in receivables

-1,510.14%-15.55M

429.46%683K

-104.69%-331K

221.35%5.67M

-270.68%-553K

-108.30%-966K

-68.69%129K

141.42%7.06M

-53.38%-4.68M

145.06%324K

-Change in prepaid assets

-14.99%1.82M

-64.09%-1.61M

-54.16%1.88M

201.38%2.2M

-491.40%-3.05M

-30.25%2.14M

79.93%-983K

464.85%4.09M

48.59%-2.17M

-38.81%779K

-Change in payables and accrued expense

-131.23%-2.28M

150.11%3.45M

55.43%-1.35M

-173.24%-1.39M

-112.12%-7.04M

48.21%7.29M

132.26%1.38M

-166.14%-3.02M

112.71%1.89M

-235.00%-3.32M

-Change in other current assets

--0

133.07%128K

193.06%201K

---211K

108.98%15K

3,175.00%123K

47.35%-387K

-2,063.64%-216K

-Change in other current liabilities

---487K

---473K

---346K

---445K

--0

----

-Change in other working capital

--1.21M

---595K

--1.43M

----

-190.48%-183K

-833.33%-140K

Cash from discontinued investing activities

Operating cash flow

-62.61%-18.2M

29.20%-12.01M

-272.46%-11.82M

-252.89%-50.93M

-72.82%-19.6M

-194.17%-11.19M

-102.04%-16.96M

51.76%-3.17M

55.71%-14.43M

-42.29%-11.34M

Investing cash flow

Cash flow from continuing investing activities

-216.67%-114K

93.65%-192K

87.71%-308K

5.86%-5.41M

126.11%153K

98.22%-36K

-47.18%-3.02M

-129.58%-2.51M

55.47%-5.75M

95.19%-586K

Net PPE purchase and sale

-216.67%-114K

93.65%-192K

87.71%-308K

5.86%-5.41M

126.11%153K

98.22%-36K

-47.18%-3.02M

-129.58%-2.51M

-401.75%-5.75M

-38.21%-586K

Cash from discontinued investing activities

Investing cash flow

-216.67%-114K

93.65%-192K

87.71%-308K

5.86%-5.41M

126.11%153K

98.22%-36K

-47.18%-3.02M

-129.58%-2.51M

55.47%-5.75M

95.19%-586K

Financing cash flow

Cash flow from continuing financing activities

910.87%465K

1,178.57%358K

-70.22%503K

476.00%1.87M

-77.48%109K

46K

28K

1,162.26%1.69M

-99.85%325K

5,277.78%484K

Net issuance payments of debt

----

--0

----

---159K

--0

Net common stock issuance

910.87%465K

293.41%358K

-71.88%503K

320.45%2.04M

-77.48%109K

--46K

--91K

--1.79M

-99.53%484K

268.64%484K

Proceeds from stock option exercised by employees

--0

Net other financing activities

----

---163K

--0

---63K

---100K

----

Cash from discontinued financing activities

Financing cash flow

910.87%465K

1,178.57%358K

-70.22%503K

476.00%1.87M

-77.48%109K

--46K

--28K

1,162.26%1.69M

-99.85%325K

5,277.78%484K

Net cash flow

Beginning cash position

-31.93%117.77M

-32.07%129.97M

-26.90%142.09M

-9.19%194.39M

-19.89%160.31M

-10.03%173.03M

-4.62%191.33M

-9.19%194.39M

394.74%214.05M

-14.44%200.1M

Current changes in cash

-59.62%-17.85M

40.66%-11.84M

-191.26%-11.63M

-174.30%-54.47M

-68.99%-19.34M

-213.33%-11.18M

-90.98%-19.95M

49.02%-3.99M

-111.20%-19.86M

43.21%-11.45M

Effect of exchange rate changes

500.97%6.18M

-121.58%-357K

-152.62%-492K

1,060.96%2.17M

-80.41%1.12M

26.28%-1.54M

-24.06%1.65M

116.61%935K

102.90%187K

1,604.17%5.73M

End cash Position

-33.81%106.1M

-31.93%117.77M

-32.07%129.97M

-26.90%142.09M

-19.89%160.31M

-10.03%173.03M

-4.62%191.33M

-9.19%194.39M

Free cash flow

-63.11%-18.31M

38.95%-12.2M

-113.52%-12.13M

-173.90%-56.34M

-63.05%-19.45M

-218.45%-11.23M

-91.25%-19.98M

25.94%-5.68M

39.02%-20.57M

-42.08%-11.93M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-62.61%-18.2M	29.20%-12.01M	-272.46%-11.82M	-252.89%-50.93M	-72.82%-19.6M	-194.17%-11.19M	-102.04%-16.96M	51.76%-3.17M	55.71%-14.43M	-42.29%-11.34M
Net income from continuing operations	42.39%-8.13M	28.88%-16.94M	14.83%-15.52M	-1,480.32%-73.45M	18.30%-17.29M	-271.63%-14.11M	-251.85%-23.82M	-807.96%-18.22M	110.41%5.32M	-39.50%-21.16M
Operating gains losses	141.73%2.61M	-87.76%443K	-129.28%-1.03M	129.82%7.53M	-43.01%6.65M	65.69%-6.24M	--3.62M	--3.5M	-432.89%-25.25M	--11.67M
Depreciation and amortization	0.07%1.48M	12.93%1.47M	17.12%1.43M	25.58%5.43M	21.92%1.44M	24.07%1.47M	30.95%1.3M	26.40%1.22M	618.11%4.32M	266.67%1.18M
Deferred tax	99.50%-3K	99.38%-7K	92.83%-37K	29.10%-3.08M	57.55%-821K	3.68%-602K	-24.15%-1.14M	40.21%-516K	-3,544.54%-4.34M	-3,292.98%-1.93M
Other non cash items	108.33%2K	-30.87%383K	18.41%431K	21.43%1.41M	191.18%517K	-104.17%-24K	-28.15%554K	-4.96%364K	0.96%1.16M	-262.93%-567K
Change In working capital	-285.20%-15.29M	168.63%1.46M	-84.43%1.29M	211.71%6.17M	-323.42%-10.88M	-57.91%8.26M	106.06%542K	160.59%8.25M	23.04%-5.52M	-185.47%-2.57M
-Change in receivables	-1,510.14%-15.55M	429.46%683K	-104.69%-331K	221.35%5.67M	-270.68%-553K	-108.30%-966K	-68.69%129K	141.42%7.06M	-53.38%-4.68M	145.06%324K
-Change in prepaid assets	-14.99%1.82M	-64.09%-1.61M	-54.16%1.88M	201.38%2.2M	-491.40%-3.05M	-30.25%2.14M	79.93%-983K	464.85%4.09M	48.59%-2.17M	-38.81%779K
-Change in payables and accrued expense	-131.23%-2.28M	150.11%3.45M	55.43%-1.35M	-173.24%-1.39M	-112.12%-7.04M	48.21%7.29M	132.26%1.38M	-166.14%-3.02M	112.71%1.89M	-235.00%-3.32M
-Change in other current assets	--0	--0	--0	133.07%128K	193.06%201K	---211K	108.98%15K	3,175.00%123K	47.35%-387K	-2,063.64%-216K
-Change in other current liabilities	---487K	---473K	---346K	---445K	---445K	--0	--0	--0	--0	----
-Change in other working capital	--1.21M	---595K	--1.43M	----	----	----	----	----	-190.48%-183K	-833.33%-140K
Cash from discontinued investing activities
Operating cash flow	-62.61%-18.2M	29.20%-12.01M	-272.46%-11.82M	-252.89%-50.93M	-72.82%-19.6M	-194.17%-11.19M	-102.04%-16.96M	51.76%-3.17M	55.71%-14.43M	-42.29%-11.34M
Investing cash flow
Cash flow from continuing investing activities	-216.67%-114K	93.65%-192K	87.71%-308K	5.86%-5.41M	126.11%153K	98.22%-36K	-47.18%-3.02M	-129.58%-2.51M	55.47%-5.75M	95.19%-586K
Net PPE purchase and sale	-216.67%-114K	93.65%-192K	87.71%-308K	5.86%-5.41M	126.11%153K	98.22%-36K	-47.18%-3.02M	-129.58%-2.51M	-401.75%-5.75M	-38.21%-586K
Cash from discontinued investing activities
Investing cash flow	-216.67%-114K	93.65%-192K	87.71%-308K	5.86%-5.41M	126.11%153K	98.22%-36K	-47.18%-3.02M	-129.58%-2.51M	55.47%-5.75M	95.19%-586K
Financing cash flow
Cash flow from continuing financing activities	910.87%465K	1,178.57%358K	-70.22%503K	476.00%1.87M	-77.48%109K	46K	28K	1,162.26%1.69M	-99.85%325K	5,277.78%484K
Net issuance payments of debt	----	----	----	--0	----	----	----	----	---159K	--0
Net common stock issuance	910.87%465K	293.41%358K	-71.88%503K	320.45%2.04M	-77.48%109K	--46K	--91K	--1.79M	-99.53%484K	268.64%484K
Proceeds from stock option exercised by employees	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Net other financing activities	----	----	----	---163K	--0	--0	---63K	---100K	----	----
Cash from discontinued financing activities
Financing cash flow	910.87%465K	1,178.57%358K	-70.22%503K	476.00%1.87M	-77.48%109K	--46K	--28K	1,162.26%1.69M	-99.85%325K	5,277.78%484K
Net cash flow
Beginning cash position	-31.93%117.77M	-32.07%129.97M	-26.90%142.09M	-9.19%194.39M	-19.89%160.31M	-10.03%173.03M	-4.62%191.33M	-9.19%194.39M	394.74%214.05M	-14.44%200.1M
Current changes in cash	-59.62%-17.85M	40.66%-11.84M	-191.26%-11.63M	-174.30%-54.47M	-68.99%-19.34M	-213.33%-11.18M	-90.98%-19.95M	49.02%-3.99M	-111.20%-19.86M	43.21%-11.45M
Effect of exchange rate changes	500.97%6.18M	-121.58%-357K	-152.62%-492K	1,060.96%2.17M	-80.41%1.12M	26.28%-1.54M	-24.06%1.65M	116.61%935K	102.90%187K	1,604.17%5.73M
End cash Position	-33.81%106.1M	-31.93%117.77M	-32.07%129.97M	-26.90%142.09M	-26.90%142.09M	-19.89%160.31M	-10.03%173.03M	-4.62%191.33M	-9.19%194.39M	-9.19%194.39M
Free cash flow	-63.11%-18.31M	38.95%-12.2M	-113.52%-12.13M	-173.90%-56.34M	-63.05%-19.45M	-218.45%-11.23M	-91.25%-19.98M	25.94%-5.68M	39.02%-20.57M	-42.08%-11.93M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data